Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,152 JPY | -0.14% | +3.54% | -0.50% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.49 for the 2024 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- With a 2024 P/E ratio at 23.27 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Most analysts recommend that the stock should be sold or reduced.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.50% | 1.69B | B+ | ||
+0.22% | 288B | A- | ||
-6.14% | 91.33B | C+ | ||
-6.25% | 43.27B | C+ | ||
+1.16% | 41.75B | B- | ||
+6.39% | 40.46B | B- | ||
+3.56% | 38.47B | B- | ||
-15.44% | 30.57B | B- | ||
-5.66% | 28.01B | A | ||
+9.21% | 24.46B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 2206 Stock
- Ratings Ezaki Glico Co., Ltd.